News

Video

Dr Peters on Understanding Mechanisms of Resistance to Immunotherapy in NSCLC

Author(s):

Solange Peters, MD, PhD
Conference|International Lung Cancer Congress

Solange Peters, MD, PhD, discusses current understandings of mechanisms of resistance to immunotherapy in non–small cell lung cancer.

Solange Peters, MD, PhD, full professor, chair, Medical Oncology, Thoracic Malignancies Programme, Department of Oncology, University Hospital of Lausanne, discusses current understandings of mechanisms of resistance to immunotherapy in non–small cell lung cancer.

Related Videos
VK Gadi, MD, PhD
Komal Jhaveri, MD, FACP
David R. Spigel, MD, chief scientific officer, Sarah Cannon Research Institute
Rene Adam, MD, PhD
Timothy Hughes, MD, MBBS, FRACP, FRCPA
Mikkael A. Sekeres, MD, professor, medicine, chief, Division of Hematology, Leukemia Section, the University of Miami Sylvester Comprehensive Cancer Center
Hetty E. Carraway, MD, MBA
Tycel Phillips, MD, MPH
Mazyar Shadman, MD, MPH
Anthony V. D'Amico, MD, PhD
Related Content
Mansoor Raza Mirza, MD
June 7th 2024

Dostarlimab With Carboplatin/Paclitaxel Shows Survival Benefits in dMMR/MSI-H Endometrial Cancer

Stephen Liu, MD; Sara A. Hurvitz, MD, FACP; S. Vincent Rajkumar, MD; Sumanta Kumar Pal, MD, FASCO; Shubham Pant, MD, MBBS
May 23rd 2024

Oncology Experts Preview Top Abstracts From the 2024 ASCO Annual Meeting

Charlene Mantia, MD, of Dana-Farber Cancer Institute
June 6th 2024

Nivolumab/Cabozantinib Combination Prolongs Treatment-Free Survival in Advanced RCC

Hari B. Keshava, MD
October 23rd 2023

Keshava Emphasizes the Importance of Lung Nodule Programs for Early Lung Cancer Detection

Ronald C. Chen, MD, MPH, FASCO, FASTRO
June 6th 2024

Intensification With Apalutamide/ADT Improves PSA PFS in Biochemically Recurrent Prostate Cancer

Erika Hamilton, MD, of Sarah Cannon Research Institute
June 5th 2024

Second-Line T-DXd Data Remain Strong in HER2+ Metastatic Breast Cancer